RevBio, Inc.


RevBio, Inc. is a clinical stage medical device company focused on developing and commercializing TETRANITE®, a patented synthetic bone adhesive biomaterial. The company aims to transform bone repair across various applications in both human and animal health, leveraging innovative technology inspired by natural materials.

REVBIO

RevBio, Inc.

600 Suffolk St. Suite #250 Lowell, MA 01854


Patents

Compositions and methods for adhesion to surfaces

2024-12-31 • US-12178937-B2

View Details

Compositions and methods for adhesion to surfaces

2024-10-22 • US-12122717-B2

View Details

Implantable objects, guiding devices, and methods of use thereof

2023-09-19 • US-11759546-B2

View Details

Compositions and methods for adhesion to surfaces

2023-05-02 • US-11638777-B2

View Details

Compositions and methods for adhesion to surfaces

2022-02-15 • US-11247941-B2

View Details

What We Do

A patented, synthetic, injectable, self-setting, load-bearing, and osteoconductive bone adhesive biomaterial that bonds bone to bone and bone to metal. It is designed for use in dental and orthopedic applications, with ongoing clinical trials to validate its efficacy.



Key People

Chief Executive Officer, Founder

Chief Operations Officer & CFO

Chief Scientific Officer


News & Updates

RevBio has received a $2.4 million NIH grant to conduct a first-in-human clinical trial for its regenerative bone adhesive for cranial flap fixation and has enrolled the first five patients.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.